Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

346 results about "Surfactant free" patented technology

Long-wearing cosmetic compositions with improved shine

A cosmetic composition comprising (A) a first structured and adhesive film-forming fatty phase comprising (i) one or more lipidic components that are mutually compatible with one another when liquefied; (ii) at least one adhesive film-forming agent; and (iii) at least one lipophilic structuring agent in an amount effective to retain a second fatty phase entrapped in said cosmetic composition prior to application on mammalian keratinous tissue; and (B) a second fatty phase comprising at least one non-volatile lipidic component wherein said second fatty phase (B) is incompatible with said first structured and adhesive film-forming fatty phase (A) and said second fatty phase (B) is entrapped in said composition where upon application of said composition to mammalian keratinous tissue, said second fatty phase (B) readily separates from said composition to form a barrier layer over said first structured and adhesive film-forming fatty phase (A) and wherein said composition is substantially free of surfactants such that separation of said second fatty phase (B) from said composition is not prevented following application of said composition.
Owner:NOXELL CORP

Oil ammonia column shaping method of spherical aluminium oxide

A process for preparing spherical alumina by oil-ammonia column includes dripping the alumina sol in the oil-ammonia column composed of upper oil phase and lower electrolyte solution phase to generate spherical gel particles, ageing in electrolyte solution for 0.5-10 hr, drying and calcining. Its advantage is high purity.
Owner:CHINA PETROLEUM & CHEM CORP +1

Anti-IL-9 antibody formulations and uses thereof

InactiveUS20050260204A1Low to undetectable levelEasy to manageAntibacterial agentsAntimycoticsDiseaseAntibody fragments
The present invention provides liquid formulations of antibodies or antibody fragments that immunospecifically bind to an IL-9 polypeptide, which formulations exhibit stability, low to undetectable levels of aggregation, and very little to no loss of the biological activities of the antibodies or antibody fragments, even during long periods of storage. In particular, the present invention provides liquid formulations of antibodies or fragments thereof that immunospecifically bind to an IL-9 polypeptide, which formulations are substantially free of surfactants, sugars, sugar alcohols, amino acids other than histidine (preferably with pKa values of less than 5 and above 7), and / or other common excipients. Furthermore, the invention provides methods of preventing, treating or ameliorating a disease or disorder associated with or characterized by aberrant expression and / or activity of an IL-9 polypeptide, a disease or disorder associated with or characterized by aberrant expression and / or activity of the IL-9R or one or more subunits thereof, an autoimmune disease, an inflammatory disease, a proliferative disease, or an infection (preferably, a respiratory infection), or one or more symptoms thereof, utilizing the liquid formulations of the present invention.
Owner:MEDIMMUNE LLC

Stabilized high concentration anti-integrin alphanubeta3 antibody formulations

The present invention provides liquid formulations of antibodies or antibody fragments that immunospecifically bind to integrin alphaVbeta3, which formulations exhibit stability, low to undetectable levels of aggregation, and very little to no loss of the biological activities of the antibodies or antibody fragments, even during long periods of storage. In particular, the present invention provides liquid formulations of antibodies or fragments thereof that immunospecifically bind to integrin alphaVbeta3, which formulations are substantially free of surfactant, inorganic salts, and / or other common excipients. Furthermore, the invention provides methods of preventing, treating or ameliorating an inflammatory disorder, an autoimmune disorder, a disorder associated with aberrant expression and / or activity of integrin alphaVbeta3, a disorder associated with abnormal bone metabolism, a disorder associated with aberrant angiogenesis or cancer utilizing the liquid formulations of the present invention.
Owner:MEDIMMUNE LLC

Consumer noticeable improvement in wetness protection

Antiperspirant compositions comprising: (a) from about 0.1% to about 30% by weight of the composition, of a high-efficacy antiperspirant active; (b) from about 0.1% to about 35% by weight of the composition, of a thickening agent; (c) from about 10% to about 99% by weight of the composition, of an anhydrous liquid carrier; (d) from about 5 ppm to about 20% by weight of the composition, of a primary fragrance; and (e) from at least about 5 ppm by weight of the composition, of a secondary fragrance that is distinct from the primary fragrance and is included in a surfactant-free, water-releasable matrix, which renders the secondary fragrance within the matrix substantially odorless prior to aqueous activation, wherein the antiperspirant composition is substantially devoid of a malodor reducing agent.
Owner:THE PROCTER & GAMBLE COMPANY

Composition in the form of an oil-in-water emulsion containing cellulose fibrils, and its uses, especially cosmetic uses

The present application relates to a composition in the form of an oil-in-water emulsion comprising an oily phase dispersed in an aqueous phase, characterized in that the composition is free of surfactant and in that it contains cellulose fibrils which have a length of greater than 1 micron and a length / diameter ratio of greater than 30. The invention also relates to the use of the composition, especially for the care, the treatment, the makeup or the cleansing of the skin, lips, eyelashes and / or hair, as well as for the care of sensitive or dry skin.
Owner:LOREAL SA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products